Lower-income countries have reached a record milestone by contributing US$302 million in 2025 toward Gavi-supported vaccine programmes, reflecting a significant rise in domestic investment in immunisation. According to new data from Gavi, this marks the highest annual contribution to date and comes amid global aid cuts and increasing pressure on external health financing.
Over the past five years, these countries have collectively mobilised US$1.1 billion for immunisation, matching the total amount raised over the previous 13 years combined. This sharp increase highlights a growing shift toward national ownership of vaccine financing, supported by Gavi’s co-financing model, which gradually increases government responsibility for immunisation costs over time.
Gavi CEO Dr Sania Nishtar noted that countries are taking a stronger role in securing the future of immunisation despite a challenging global financing environment. She emphasized that record co-financing demonstrates progress toward more sustainable, country-led immunisation systems that better protect children from preventable diseases.
The report also shows strong compliance with co-financing obligations in 2025, with nearly all eligible countries meeting their commitments, including many operating under fragile or conflict-affected conditions. This reflects continued prioritisation of immunisation in national budgets even amid economic and humanitarian pressures.
Since 2008, total country contributions have reached US$2.2 billion, and this momentum is expected to grow further as Gavi moves into its 2026–2030 strategic phase. The continued rise in domestic financing underscores the long-term shift toward self-sustaining immunisation systems, which have already helped prevent millions of deaths and generated substantial social and economic returns globally.
